Article
Carriers of heterozygous loss-of-function ACE mutations are at risk for Alzheimer’s disease
2023-03-06
Abstract excerpt
Amyloid Aβ42 (constituents of the protein aggregates in the brains of patients with Alzheimer’s disease (AD) cleaved by ACE, and thus, a decrease in tissue ACE activity (constitutive or ACE inhibitor-induced) could be risk factor for AD. We hypothesized that subjects with heterozygous Loss-of-Function (LoF) ACE mutations are at risk for Alzheimer’s disease. Existing SNP databases were analyzed for LoF ACE mutation...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 356587f7-46c4-516d-bdda-7e7b90a1697e
- DOI
- 10.21203/rs.3.rs-2570701/v1
